David Utley, M.D., is a cancer surgeon and innovator in the fields of digital health and medical devices. He is the founder and CEO of Carrot Sense, a digital behavioral health company whose first product, Pivot, is aimed at revamping the way smoking cessation programs are designed and delivered. Pivot utilizes mobile sensors, personal coaching, evidence-based strategies, and consumer-grade design to engage and empower people to quit smoking on their own terms.
Prior to Carrot Sense, Dr. Utley was the founder and chief medical officer of BARRX Medical, a company that developed a minimally invasive approach for treating early esophageal cancer. BARRX was acquired by Covidien in 2012.
Dr. Utley graduated from Harvard Medical School in 1992 and did his surgical residency training at Stanford. He then joined the surgical faculty at Stanford and the VA Palo Alto, where he focused on the treatment of patients with head and neck cancer. He left Stanford in 2003 to start BARRX Medical.
Dr. Utley has served as founder, chief medical officer, or member of the board of directors for several medical device companies, including Somnus Medical Technologies (ENT), Curon Medical (GI), Aetherworks (pulmonary), BAROnova (GI), Freedom-2 (plastics), and CoAlign Innovations (spine). He is also the inventor on 65 issued U.S. patents and more than 100 published U.S. patents, including several for the technologies at the heart of Pivot.